Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Vicarious Surgical Inc’s stock clocked out at $0.28, up 3.70% from its previous closing price of $0.27. In other words, the price has increased by $3.70 from its previous closing price. On the day, 0.53 million shares were traded. RBOT stock price reached its highest trading level at $0.295 during the session, while it also had its lowest trading level at $0.2665.
Ratios:
To gain a deeper understanding of RBOT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.87 and its Current Ratio is at 13.87. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on March 04, 2022, Downgraded its rating to Neutral and sets its target price to $7 from $16 previously.
On January 07, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $16.
On December 07, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $15.Cowen initiated its Outperform rating on December 07, 2021, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 20 ’24 when Sachs Adam David sold 4,830 shares for $0.34 per share. The transaction valued at 1,653 led to the insider holds 1,730,220 shares of the business.
Khalifa Sammy sold 3,863 shares of RBOT for $1,316 on Mar 20 ’24. The Chief Technology Officer now owns 1,215,977 shares after completing the transaction at $0.34 per share. On Mar 20 ’24, another insider, Kelly William John, who serves as the CFO and Treasurer of the company, sold 1,290 shares for $0.34 each. As a result, the insider received 437 and left with 517,841 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RBOT now has a Market Capitalization of 47529440 and an Enterprise Value of -34134532.
Stock Price History:
The Beta on a monthly basis for RBOT is 1.19, which has changed by -0.8733032 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, RBOT has reached a high of $2.45, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -15.28%, while the 200-Day Moving Average is calculated to be -52.20%.
Shares Statistics:
It appears that RBOT traded 583.39K shares on average per day over the past three months and 317120 shares per day over the past ten days. A total of 155.89M shares are outstanding, with a floating share count of 71.41M. Insiders hold about 59.43% of the company’s shares, while institutions hold 19.52% stake in the company. Shares short for RBOT as of 1713139200 were 6170733 with a Short Ratio of 10.58, compared to 1710460800 on 5769615. Therefore, it implies a Short% of Shares Outstanding of 6170733 and a Short% of Float of 5.79.
Earnings Estimates
The current rating of Vicarious Surgical Inc (RBOT) reflects the combined expertise of 4.0 analysts actively engaged in assessing its market performance.On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.12, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.34 and -$0.48 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.4, with 4.0 analysts recommending between -$0.36 and -$0.49.
